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It was found by BiUingham and Brent (1), by Simonsen (2),  and by Wood- 
ruff and Sparrow (3) that a considerable percentage of newborn mice, rats, and 
chicks which were treated with adult, homologous spleen cells, lymph node ceils, 
buffy coat leucocytes  (4), or thymus ceils  (4), after an initial  period of  ap- 
parently normal growth, became ill, exhibited a failure to grow at a normal rate, 
and died by 4 weeks of age. This disease has been referred to as the runting 
syndrome. 
It has been reported that runted mice exhibit diarrhea (3, 4), an anemia with 
a  positive Coombs test (2), splenomegaly (2,  5, 6), hepatomegaly (5, 6),  and 
atrophic changes of their lymphoid tissue (1,  2, 4,  7).  Billingham and his co- 
workers found that the incidence of mating in mice varied with different strain 
combinations (4), being greater with greater genetic disparity between donor 
and recipient (4).  They also found that the rtmted mice were tolerant of skin 
grafts from the original cell donor's strain (1, 4). Simonsen (2) found that blood 
from adult chicks produced splenic enlargement if given to  chick embryos, 
while blood from newborn chicks was not active. Mechanical disruption of the 
cells  in  a  Potter  homogenizer destroyed their  spleen-enlarging activity (2). 
Inoculation of parent strain newborn mice or chicks with spleen cells from the 
F 1 hybrid of that strain with some other strain failed to produce runting (4-5); 
while parent strain spleen cells  produced mating of newborn F 1 hybrid ani- 
mals (5). 
Most workers in the field (1, 2) have considered the mating syndrome to be 
the result of an immunological reaction of the grafted spleen cells  against a 
tolerant host. 
It is  the  purpose  of  this  paper  to  explore  further certain  aspects  of the 
runting  syndrome,  including several immunological methods  for  protecting 
newborn mice against the development of the syndrome. 
Materials  and  Methods 
M/ce.--The mice used in these experiments  were, in most eases, DBA/2, A/Jax, C57B1/6, 
Balb/c, CBA, C57Br, and CAF  t inbred strains obtained from the Jackson Memorial  Labora- 
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tory, Bar Harbor, Maine, and maintained on Wayne Lab blox mouse pellets and water ad 
libitum.  In some experiments Swiss  Webster newborn mice were employed. 
Cell Donors.--The  cell donors were 6 to 10 week old inbred mice of the strains mentioned 
above, housed in cages containing ten mice per cage, and provided with food and water as 
described above. 
Cell Rexipients.--The  cell recipients were newborn mice of the strains mentioned above. 
Newborn mice were obtained either from pregnant mice supplied by the Jackson Memorial 
Laboratory or from our own colony of breeders established with breeding stock obtained from 
the Jackson Memorial Laboratory. Breeding mice were housed three mice (two females and 
one male) per cage and supplied with food and water ad libitum. Each cage was examined once 
daily for newborn animals. After treatment, newborn mice were returned to and left with their 
own mothers. 
Spleen Cell Preparations.--Donor mice were sacrificed  by cervical dislocation, spleens were 
removed intact, and passed through a garlic press. The mash was then suspended, by vigorous 
pipetting, in sterile normal saline so that the material from three spleens was suspended in 
1 ml. of saline.  Each newborn mouse, unless otherwise stated in the text, received 0.05  ml. 
of this suspension intraperitoneally. Cell counts were performed on randomly selected prepa- 
rations and proved to be fairly constant, with each newborn mouse receiving between eight 
and twelve million nucleated spleen cells. 
Cell suspensions  of other organs (liver, kidney, and mesenteric lymph node) were prepared 
in a similar manner. 
lnjevtion of Newborn M/ce.--All injections of newborn mice were given tga the intraperi- 
toneal route. To avoid leakage, a  27 or 30  gauge needle was employed and the needle  was 
passed through the animal's thigh muscle and into the peritoneal cavity. Injections of foreign 
cells,  unless otherwise stated,  were always given within 24 hours after birth. 
Preparation of Serum.--Anti-C57B1/6 serum was prepared  by immunizing 6  to 8  week 
old DBA/2 male mice with adult C57B1/6 spleen cells. Recipients received initial intraperi- 
toneal injections of 0.5 ml. of saline suspension  containing two-thirds of a  C57B1/6 spleen 
per ml. Two weeks later, each received approximately 0.1 ml. of an emulsion, prepared from 
a suspension containing three C57B1/6 spleens per ml. mixed with an equal volume of Difco 
completebacto-adjuvant (containing an added 50 nag. of Difco dried Mycobacterium butyrivum 
per 10 ml. Difco complete adjuvant), into the four toepads. One week later, each mouse re- 
ceived a  second  similar injection of C57B1/6 cells with complete adjuvant into the toepads. 
The mice were bled, by indsion of the retroorbital plexus,  1 week after the final immunization. 
The blood was allowed to clot and cell-free serum was prepared by centrifuging twice at 2500 
R.P.M. for 20 minutes. 
Serum  Treatrnent.--Newborn  mice treated with serum  received daily intraperitoneal  in- 
jections of serum, starting 2 days after birth, according to the following dosage schedule: 
No. of days after birth  MI. of serum 
0.02 
0.05 
0.07 
0.10 
0.I0 
0.I0 
0.i0 
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Cm'terion for Runting.--The runting syndrome as seen in newborn mice receiving homolo- 
gous spleen or lymph node cells consists of failure to grow at a normal rate, diarrhea, anemia, 
focal coaguiative necrotic liver lesions, splenomegaly,  and death within 2 to 3 weeks  after 
birth. All of the above occur in various combinations in runted mice. Because of the simplicity 
of measurement,  sharpness of endpoint, and reliability,  we chose death of the mouse between 
6 and 30 days after birth as our criterion for runting. This criterion generally included all 
mice which  would  be considered  runts according  to the other possible criteria mentioned 
above. Deaths occurring during the first 5 days after birth were regarded as consequent  upon 
the administration of a relatively large volume of fluid to a newborn mouse; and mice dying 
during this period were not considered in calculations  of runting incidence reported in this 
paper. Mice surviving 30 days in almost all cases were of normal size and appeared healthy. 
EXPERIMENTAL 
Factors Influencing Runting Syndrome.--To  determine what types of tissues, 
other than homologous spleen cells, would produce runting, newborn mice were 
TABLE I 
Effect of Spleen and Liver Cells Given to Mice within 24 Hours o 'ter  Birth 
Incidence  of death 
Type of tissue  Source  between 6 and 30 
days of age 
18/25 
Litter mate controls 
Litter mate controls 
(Balb/c) 
Lymph node 
Liver 
Spleen 
No treatment 
f 
Spleen 
Spleen 
No treatment 
Homologous 
Homologous 
Homologous 
Homologous 
Isologous 
2/16 
11/14 
1/17 
8/8 
2*/28 
0/9 
* These two animals died 20 and 26 days after birth and were of normal size and did not 
show liver lesions on autopsy. 
treated with saline suspensions of homologous liver cells, homologous kidney 
cells,  homologous  mesenteric  lymph  node  cells,  and  isologous  spleen  cells 
within 24 hours after birth. As indicated in Table I, homologous adult mesen- 
teric lymph node cell suspensions also caused runting. 
Litters of newborn mice were divided into three groups: one group received 
homologous  liver  cell  suspensions;  the  second  group  received  homologous 
spleen cell suspensions;  and  the third group was  left untreated.  As indicated 
in Table  I,  the  animals which  had  received homologous spleen cells became 
runted,  while animals which  had  received homologous  liver ceils were  unaf- 
fected.  The  weights  of  animals  which  had  received  homologous  liver  cells 
were approximately equal to those of their litter mate controls. 
Twenty-four  Swiss  Webster  newborn  mice  received  C57Br  kidney  cell 514  RUNTING SYNDROMF. 
suspensions.  Three died during the first 3  days after birth. The remaining 
twenty-one appeared normal. Twelve were sacrificed for blood studies between 
10 and 25 days after birth. None showed any abnormalities  on autopsy and 
all had normal red blood cell counts. Nine were allowed to grow to maturity. 
These were alive and well 40 days after birth, when they were sacrificed, and 
showed no lesions on autopsy. 
Litters of Balb/c mice were randomly divided into three groups: one group 
received C57B1/6 spleen cells; the second group received Balb/c adult female 
spleen  cells;  and the  third  group was  untreated.  As  indicated in Table  I, 
isologous spleen cells failed to produce runting, 
The effect of different  conditions  of  administration of homologous spleen 
TABLE II 
Incidence of Runting with Various Strain Combinations of Mice 
Donor strain  Recipient strain  Inddence of runting 
C57B1/6 
C57B1/6 
C57B1/6 
C57B1/6 
C57B1/6 
C57B1/6 
C57Br 
CBA 
Balb/c 
A/Jax 
A/Jax 
CAF  I 
DBA/2 
Balb/c 
Swiss Webster 
CBA 
DBA/2 
A/Jax 
DBA/2 
CBA 
78/79 (99%) 
32/32 (100%) 
78/85 (92%) 
38/41  (93%) 
33/40 (82%) 
16/16 (100%) 
14/14 (100%) 
9/20 (45%) 
4/16 (25%) 
17/22  (77%) 
cells upon the incidence of runting was studied. It was found, as  shown in 
Table II, that the incidence of runting depends upon the particular combina- 
tion of donor and recipient  strains employed.  Spleen cell preparations were 
made, and injections performed as described in the methods section. 
Newborn mice were  treated with one-fifth  the usual dose  of spleen  cells 
within 24 hours after birth. As shown in Table III, the incidence of runting 
decreased as one decreased the dose of homologous spleen cells administered. 
Mice were given homologous spleen cell suspensions, prepared and adminis- 
tered as indicated in the methods section,  at different times after birth. As 
shown in Table IV,  the incidence of runting decreased  as the time interval 
between birth and the administration of the homologous spleen cells increased. 
Little runting is seen when the spleen cell injection is delayed more  than 4 
days after birth. 
Liver Lesions in Runted Mice.--A characteristic lesion of liver necrosis was 
frequently observed in mice suffering from the runting syndrome. In the gross, 
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free edge of the liver. Microscopically,  the lesion was a focal area of coagulative 
necrosis associated with little or no cellular inflammatory reaction. The lesions 
were  generally of subcapsular  distribution,  although some  centrally located 
lesions were seen. 
TABLE III 
Influence of Dosage of Spleen Cells in Incidence of Runting 
Donor strain 
C57B1/6 
C57B1/6 
C57B1/6 
Recipient  strain 
DBA/2 
A/Jax 
Swiss Webster 
Dosage of spleen cell suspension* 
0.05 ml. 
78/85 (92%) 
78/79 (99%) 
33/40 (82%) 
0,01 ml. 
15/26 (58%) 
2/6  (33%) 
7/50 (14%) 
* Spleen cell suspension prepared with three adult mouse spleens per ml. 
TABLE IV 
gunting Incidence with Spleen Cell Injection at Various Times after Birth 
Donor strain 
C57B1/6 
C57B1/6 
C57B1/6 
C57B1/6 
C57B1/6 
Recipient  strain 
Balb/c 
A/Jax 
CAF  x 
DBA/2 
Swiss Web- 
ster 
1. 
38/41 
(93%) 
78/79 
(99%) 
32/32 
(lOO%) 
78/85 
(92%) 
33/40 
(82%) 
Age of mice when injected 
19/24 
(79%) 
12/14 
(86%) 
15/24 
(62%) 
23/31 
(74%) 
6/16 
(37%) 
3 
SllO 
(5o%) 
18/14 
(93%) 
4/11 
(36%) 
8/75 
(11%) 
7/14 
(so%) 
5/20 
(25%) 
12/68 
(18%) 
6/16 
(38%) 
6/2s 
(24%) 
0/11 
* 1 =  day of birth. 
To determine the incidence of the liver lesion in mice receiving homologous 
spleen,  DBA/2 and A/Jax newborn mice were treated with C57B1/6 spleen 
as described in the methods section. A/Jax mice were sacrificed between 11 
and 14 days of age and DBA/2 mice were sacrificed when 9 to 10 days of age. 
All mice were examined for the presence of gross liver lesions. 
Sixty-five out of seventy-two, or 90 per cent,  of the treated A/Jax mice 
were found to have liver lesions  visible  in  the  gross,  of the  type described 516  RUNTING  SYNDROME 
above.  Twenty-nine out  of thirty-seven, or  78  per  cent,  of treated  DBA/2 
mice had similar lesions. 
Anemia  in  Runted  Mice.--Newborn  mice  were  treated  with  homologous 
spleen,  homologous  liver,  or  isologous  spleen,  as  described  in  the  methods 
section. At various times after birth, the animals were bled from the retroorbi- 
tal plexus and white and red blood cell counts performed. 
It was found, as shown in Table V, that many of the runted mice had anemia 
of variable degree, with red cell counts averaging less  than 3 million during 
the first  10 days after injection of spleen ceils. The white blood cell counts 
ranged from leukopenia as low as 250, to leucocytosis as high as 21,700.  Much 
greater variability was  seen in  the  white blood cell counts of runted mice, 
than in those of normal mice or of mice which had received homologous liver 
TABLE  V 
Averages  of Red Blood  Cell Counts  on Mice  Treated  with Homologous  and Isologous  Tissues 
within  24 Hours  after  Birth 
Age  Untreated  Received homologous Received homologous  Received isologous 
spleen  kidney  spleen 
days 
5-10 
11-16 
17-22 
23-25 
5.14"  (18)5 
6.38  (37) 
7.9o  (8) 
8.21  (4) 
2.93  (6) 
4.87  (21) 
6.10  (4) 
4.90  (2) 
6.43  (4) 
8.69  (2) 
8.18  (5) 
6.o4  (6) 
8.50  (3) 
* Numbers indicate red cell counts, expressed  as millions of cells per cubic milliliter. 
Figure in parenthesis indicates number of mice upon which counts were done, 
or isologous spleen.  Mice which  had  received homologous liver or isologous 
spleen showed normal red blood cell and white blood cell counts. 
Necessity for Living Cells to Produce Runting.--Several experiments reported 
below were designed to determine whether viable cells were required to produce 
the runting syndrome and to rule out the possibility of an infectious agent as 
the cause of runting. 
Spleen cell suspensions were prepared as indicated in the  methods  section. 
Half of each suspension was then subjected, three times, to rapid freezing and 
thawing,  while  the  other  half  was  left untreated.  Each  litter  of mice  was 
divided randomly into two groups: one received the frozen-thawed spleen cell 
suspension,  while  the  other  received  the  untreated  spleen  cell  suspension. 
DBA/2,  A/Jax,  and CBA mice were used as recipients.  C57B1/6 mice were 
used as spleen cell donors. Out of fifteen mice receiving untreated spleen cells, 
thirteen or 87 per cent became runted, while of twenty mice receiving frozen- 
thawed spleen, only two or 10 per cent died and these two were of normal size 
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Suspensions containing six C57B1/6 spleens per ml. of saline were prepared. 
The  suspensions  were  homogenized in  a  Potter homogenizer  for  10  to  15 
minutes. Each of nine newborn A/Jax mice received 0.05  nil. of  this homog- 
enate within 24  hours  after birth. These mice grew normally, were sacrificed 
after 15 days, and examined in the gross and microscopically for liver lesions 
and splenomegaly. No abnormalities were observed. 
C57B1/6 spleens were ground with a mortar and pestle and then suspended 
in saline so as to have suspensions of 6 spleens per ml. These suspensions were 
centrifuged at 2,500 a~.P.M, for 30 minutes. Each newborn mouse received 0.05 
mi. of the cell-free supernatant with,.'n 24 hours after birth. Of the twenty-two 
mice so treated, two died when 11 days old. The remaining twenty mice ap- 
peared  normal  and were  sacrificed  15  days after birth.  No  liver  lesions  or 
splenic enlargement was found in  any of these mice,  either in  the  gross or 
microscopically. 
Since spleen ceils which had been subjected to freezing and thawing or homog- 
enization failed to  cause runting, as did also the cell-free  extracts of cells,  it 
seems reasonable to conclude that viable, intact cells are necessary to produce 
the syndrome. 
Protection again,  t Runting Syrdrome.--Preventlon by treatment with isologous 
adult spleen cell suspension,: It was thought that isologous adult spleen cells, 
by providing the newborn mouse with the ability to react  immunologically 
against foreign tissues, might protect it from rnnting. 
All animals in each of several litters received homologous spleen as previously 
described.  The  litters  were  then  randomly divided: one  group  received  no 
further treatment; the other group received 0.05 ml. of a suspension of 4 isol- 
ogous spleens per nil. of saline, intraperitoneally, within 30 minutes following 
the injection of homologous spleen. Other fitters were divided into three groups: 
the  first  group  received  no  further  treatment;  the  second  group  received 
isologous spleen,  as described above; and the third group received isologous 
liver. The fiver cell suspensions were prepared so as to be equivalent in concen- 
tration with the isologous spleen  cell  suspensions on a  wet weight basis.  A 
number of fitters were divided into two groups: one group received no further 
treatment; the other group received isologous fiver cell suspensions as above. 
Balb/c, CBA, A/Jax, and DBA/2 mice were used as recipients. C57B1/6 mice 
were used as spleen donors. 
Our experimental results, shown in Table VI, indicate that isologous spleen 
cells given to newborn mice within 30 minutes following injection of homologous 
spleen  cells  conferred  significant protection  against  the  runting  syndrome. 
None of the twenty-three mice which received only homologous spleen cells 
survived 30 days, whereas thirteen out of twenty-one, or 62 per cent, of the 
mice treated with isologons spleen cells survived and were well at that time. 
Those mice which died despite treatment with isologous spleen cells tended to 518  RU~T~O  SX'gDRO~ 
live longer than did their untreated litter mates. The data further show (see 
Table VI)  that isologous adult liver cells, given within ~-hour following in- 
jection of homologous spleen cells,  conferred no protection against runting. 
All of twenty mice treated with isologous liver cells died before 20 days of age. 
It was  necessary that treatment with isologous spleen cells  be  instituted 
soon after the injection of homologous cells in order to prevent ranting. When 
the injection of lsologous cells was delayed until 24 hours after birth, no pro- 
tection was demonstrable (Table VI). 
Protection against Runting by Antiserum against tke Homologous Strain.--It 
was next considered that newborn animals which had received foreign spleen 
TABLE VI 
Protection by Adult Isologous Spleen Calls against. Runting Syndrome When Given within 30 
Minutes after Homologous Spleen 
Group 
Newborn mice  given  homologous  spleen cells 
Newborn mice given homologous  spleen and isol- 
ogous spleen 30 rain. later 
Newborn mice given homologous  spleen and isol- 
ogous liver 30 rain. later 
Newborn mice given homologous  spleen and isol- 
ogous spleen 1 day later 
o. of 
47 
21 
20 
19 
No. of mice dying 
Day of death 
Oi  0  0 
s  12  31  ol  o! 
I 
i 
3  11  3  0  0] 
Surviv* 
ing 
days 
o 
13 
o 
2 
cells  might be protected against runting by treatment with serum prepared 
from mice immunized against the spleen cell donor's strain. 
In these experiments, newborn DBA/2 mice were used as recipients  and 
adult CS7B1/6 mice as spleen cell donors. Anti-C57B1/6 serum was prepared 
in DBA/2 adult mice as indicated in the methods section. All mice were given 
homologous spleen, as previously described, and then each litter was randomly 
divided: one group was treated with normal DBA/2 serum; the second group 
was treated with DBA/2 anti-CS7B1/6 serum. In some litters, a  third group 
which received only homologous spleen was included. Animals were treated 
with serum daily, from 2 days through 9 days after birth, as indicated in the 
methods section. 
The results, summarized in Table VII, indicate that the "anti-donor strain" 
serum was effective in protecting animals receiving homologous spleen from 
becoming runted. Normal mouse serum provided no protection against runting. 
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Cell Donor.--In view of the finding  that  serum from immunized mice could 
protect  against  runting,  it  was  considered  that  immunization  of  mothers 
against the spleen ceil donor strain, prior to parturition,  might, as a result of 
passage of antibody from the mother  to the offspring,  protect the newborn 
against runting. 
One group of experiments was performed using Balb/c mothers and C57B1/6 
spleen cell donors. The Balb/c females were immunized against C57B1/6 mice 
by means of repeated intraperitoneal  injections of C57B1/6 spleen cell sus- 
pensions in saline.  Animals born to these mothers, mated with normal Balb/c 
males, were treated with C57B1/6 spleen as described previously. As shown in 
TABLE  VII 
Protection by Anti-Serum against Homdogous Spleen Cells 
Incidence  of hinting* 
DBA/2 litter No. 
Received normal  Received DBA/2 
DBA/2 serum  anfi-C57B1/6 serum  No serum treatment 
1/2 
2/2 
a/1 
3/3 
4/4 
1/1 
2/2 
O/2 
0/2 
1/2 
1/4 
0/3 
0/2 
3/3 
1/1 
3/3 
2/3 
Total ...........  14/15  5/18  6/7 
* All received C57B1/6 spleen cells on day of birth. 
Table VIII, in the offspring  d  two d  the treated mothers,  we observed no 
decrease in the incidence d  runting as compared with the offspring of untreated 
mothers, whereas,  in the case of two other treated mothers, a marked decrease 
was observed in the incidence  of runting  (from 93 per cent with offspring  of 
untreated mothers to 25 and 20 per cent with offspring d  immunized mothers). 
A second series  of experiments was carried out, using A/Jax mothers  and 
C57BI/6 spleen cell donors.  The mothers were immunized against  C57BI/6 
mice by repeated inoculation with C57BI/6 spleen cell suspensions  in complete 
Freund's adjuvant into the toepads. The offspring d  these females mated with 
normal  A/Jax males,  were treated  with  C57BI/6 spleen cell suspensions  as 
described above. The data from these experiments,  as shown in Table  VIII, 
indicate that immunization of A/Jax mothers regularly reduced the incidence 
of runting from the 99 per cent normally seen with this strain combination to 
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DISCUSSION 
It has been suggested by previous workers (1, 2) that the runting syndrome 
is the result of an immunological reaction of the foreign cells against a tolerant 
host. The data presented here are consistent with this hypothesis. 
The cells which produce  runting are derived from lymphoid tissues  (spleen 
or  lymph node),  generally  assumed  to  be  involved in  antibody formation. 
Liver and kidney cells in comparable concentrations  are not capable of causing 
runting. The donor must be genetically different from the recipient;  lsologous 
spleen does not cause runting. 
The decrease in the incidence of runting which was observed to occur as the 
interval between birth and the time of administration of homologous spleen 
TABLE VIII 
Incidence of Runting  in Litters from Mothers Immunized  against Homologous Spleen  Cells 
Recipient strain and treatment  Breeding cage No.  Incidence of runtlug 
Balb/c mothers  immunized  against C57B1/6 
Balb/c mothers  immunized  against C57B1/6 
Balb/c mothers  immunized  against C57B1/6 
Balb/c mothers  immunized  against C57B1/6 
Balb/c mothers  untreated 
A/Jax mothers  immunized  against C57B1/6 
A/Jax mothers  untreated 
I 
II 
III 
IV 
V 
YI 
VII 
VIII 
11/12 (92%) 
3/12 (25%) 
2/10 (2O%) 
9/10  (9O%) 
38/41  (93%) 
4/20 (20%) 
78/79 (99%) 
cells was increased is of interest in view of a similar decrease in the induction 
of skin graft tolerance, reported by Billingham and Brent (1). This parallelism 
suggests that tolerance may be necessary in order to permit the foreign spleen 
cells to survive  long enough  to cause runting. The failure of frozen-thawed 
cells, homogenized  cells, and cell-free supernatant from ground spleen  sus- 
pensions to cause runting, indicates  the necessity of viable, intact cells in the 
syndrome, and tends to exclude the possibility that runfing is due to the trans- 
mission of an infectious agent from the spleen donor to the newborn  animal. 
Such procedures as freezing and thawing, and homogenizing would be expected 
to destroy the immunological reactivity of cells, but it is unlikely that any 
known bacteria or viruses would be completely eliminated by these measures. 
Similar  results  with  homogenized  cells have  been  reported  previously  by 
Simonsen (2). 
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runted  mice  is  obscure.  The  pathological  appearance  is  consistent  with  an 
ischemic origin. The possibility that the lesion is of an infectious nature resulting 
from seeding  of the liver with organisms  arising in the intestines  cannot be 
ruled out. Infections would not be unlikely in animals  as debilitated as the 
runted animals  become. Two other possible causes for these lesions  must be 
considered:  (a) vascular occlusion due to agglutination  of red blood cells as a 
result of the action of antibodies formed by the foreign spleen ceils, and  (b) 
direct immunological reaction of the foreign cells against the liver tissue. To 
the vascular occlusion hypothesis one can raise the objections that infarcts of 
the liver are very unusual, and that if this were the actual pathogenesis, one 
would expect to find thrombotic lesions in other organs in addition to the liver 
and such lesions have not been found. No evidence can be offered for or against 
the hypothesis of a  direct immunological  reaction of the foreign cells against 
the host liver tissue being the origin of the lesions observed. 
It was shown by Billingham,  Brent,  and Medawar (8)  that  tolerance can 
be eliminated by treating the tolerant animal with adult isologous lymph node 
cells. The finding that runting can be prevented by treatment of the mice with 
isologous  adult spleen cells may indicate an analogous situation. The efficacy 
of this procedure in protecting against runting may lie in its ability to prevent 
the animal  from becoming "tolerant."  That  is,  by providing it  with  adult, 
immunologically competent cells, capable of reacting against the foreign spleen 
cells,  the animal  may be prevented from becoming "tolerant."  If,  as seems 
likely,  tolerance  is  a  prerequisite  for  runting,  preventing  the  animal  from 
becoming tolerant would inevitably protect it from runting.  It is possible that 
by providing the newborn mouse with adult spleen cells, it is converted into 
an essentially immunologically mature state, in which it is unable to become 
tolerant  of foreign tissue and  so will not become runted.  The failure of isol- 
ogous liver cells, which are immunologically inactive, to protect against runting 
is consistent with this hypothesis. The failure of isologons spleen, administered 
24 hours after the injection of homologous spleen, to protect against runting is 
a  surprising  finding.  Possibly,  the  foreign  spleen  ceils  multiply  sufficiently 
rapidly, so that, with 1 day's head start, they are able to achieve some sort of 
"privileged position" in which it is  impossible  to destroy them  before they 
have sufficiently  damaged the host to result in the latter's death. 
The ability of immune serum, directed against the spleen cell donor strain, 
to protect against  runting  strongly suggests that  some factor in  the serum, 
presumably antibody, is able to destroy the foreign  cells or render them im- 
munologically inactive.  The finding  that offspring  of immunized mothers are 
protected against runting when given spleen cells from the strain against which 
the mother had been immunized,  is interpreted as indicating the passage, from 
mother to offspring, in the colostrum or across the placenta, of antibody directed 522  RUNTING  SYNDROME 
against  the  donor  line  of  cells.  Parenthetically,  these  observations  furnish 
indirect  evidence  to  support  the  theory  that  circulating  antibody  may  be 
involved in the rejection of homografts. 
SITM:I~ARY  AND CONCLUSION 
Runting was  produced by  homologous  spleen  or  lymph node  cell  suspensions, 
but  not by isologons  spleen  or  homologous liver  or  kidney cell  suspensions. 
The incidence  of runting  (a) varied  with the particular  strain  combination 
employed, (b) increased with increased dose of foreign cells, and (c) decreased 
as the time interval between birth and inoculation with foreign cells was in- 
creased. 
A focal, coagulative necrotic,  liver lesion was described in runted mice. 
It was found that viable cells were required to produce the runting syndrome. 
Frozen-thawed cells, homogenized  cells, and the cell-free supernatant of ground 
spleen suspensions  failed to produce runting. 
Runted mice were found to have an anemia of variable degree,  and white 
blood cell counts ranging  from marked leukopenia to severe leucocytosis. Mice 
receiving  isologous  spleen or homologous  liver or kidney showed normal  red 
and white blood cell counts. 
Isologous spleen cells, given to newborn mice within 30 minutes following 
injection  of homologous  spleen cells,  conferred significant  protection against 
the runting  syndrome. Isologons spleen injected 1 day after the injection of 
homologous  spleen failed to  protect.  Newborn mice which had received ho- 
mologous spleen cells were protected from becoming runted by treatment with 
"anti-cell donor strain"  serum. The offspring of mothers which had been im- 
munized against the spleen cell donor's strain failed to become runted when 
treated with homologous spleen cells. 
The data are regarded as compatible with the concept, presented by previous 
workers,  that  runting  is  the result  of an  immunological  reaction of foreign 
cells against a tolerant host. 
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